Stay updated with breaking news from Polypeptide Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Metabolic Disorders Drug market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key ma...
In comparison to 2019, which reported a transaction value amounting to USD 127bn, 2020 was quite an unusual year due to the global pandemic accompanied by the uncertainty of the economic impact caused by COVID-19.
SIX Swiss Stock Exchange Reports CHF 108.2M Net Profit in H1 2021, Launches 40 Crypto-related ETPs July 25, 2021 @ 7:58 pm By Omar Faridi SIX, the Swiss Stock Exchange which is Europe’s 3rd-largest stock exchange and one the industry’s most-respected post-trade providers, is reporting a “solid” set of results for the first half of 2021. The SIX Swiss Exchange, based in Zurich and serving as Switzerland’s principal stock exchange, reveals that during H1 2021, it managed to generate “operating income of CHF 745.8 million (+19.5%), and earnings before interest, tax, depreciation and ...
EQS Group-Ad-hoc: PolyPeptide Group / Schlagwort(e): Personalie PolyPeptide Group ernennt Christina Del Vecchio zum General Counsel und Mitglied der Geschäftsleitung 25.06.2021 / 07:00 CET/CEST Veröffentlichung
The Peptide Therapeutics Market Growth impelled by growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and...